17th week of 2020 patent applcation highlights part 24 |
Patent application number | Title | Published |
20200123158 | NOVEL COMPOUNDS AND THEIR USE IN THE TREATMENT OF SCHISTOSOMIASIS | 2020-04-23 |
20200123159 | MANUFACTURING PROCESS AND INTERMEDIATES FOR A PYRROLO[2,3-D]PYRIMIDINE COMPOUND AND USE THEREOF | 2020-04-23 |
20200123160 | IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION | 2020-04-23 |
20200123161 | ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND USES THEREOF | 2020-04-23 |
20200123162 | SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020-04-23 |
20200123163 | TDO2 and IDO1 Inhibitors | 2020-04-23 |
20200123164 | SALT OF CETAGLIPTIN, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION, AND USE THEREOF | 2020-04-23 |
20200123165 | KINASE INHIBITORS | 2020-04-23 |
20200123166 | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS | 2020-04-23 |
20200123167 | FUSED TRICYCLIC PYRIDAZINONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS | 2020-04-23 |
20200123168 | MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF | 2020-04-23 |
20200123169 | SELF-EXFOLIATED TRIAZOLE-TRIFORMYL PHLOROGLUCINOL BASED COVALENT ORGANIC NANOSHEETS FOR HIGH AND REVERSIBLE LITHIUM ION STORAGE | 2020-04-23 |
20200123170 | COMPOSITIONS AND METHODS FOR INHIBITING VIRAL INFECTION | 2020-04-23 |
20200123171 | 4Beta-Amidotriazole Linked Podophyllotoxin Derivatives as Potential Anticancer Agents | 2020-04-23 |
20200123172 | COT MODULATORS AND METHODS OF USE THEREOF | 2020-04-23 |
20200123173 | TOPOISOMERASE INHIBITORS WITH ANTIBACTERIAL AND ANTICANCER ACTIVITY | 2020-04-23 |
20200123174 | NOVEL PTEFB INHIBITING MACROCYCLIC COMPOUNDS | 2020-04-23 |
20200123175 | NOVEL ISOTHIAZOLO-BASED BICYCLES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND/OR PLANT GROWTH REGULATORS | 2020-04-23 |
20200123176 | PYRIMIDINONES AS PI3K INHIBITORS | 2020-04-23 |
20200123177 | PYRROLOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF INFLUENZA VIRUS REPLICATION | 2020-04-23 |
20200123178 | Novel Process for the Preparation of Gadolinium Complex of (4S)-4-(4-Ethoxybenzyl)-3,6,9-Tris(Carboxylatomethyl)-3,6,9-Triazaundecan- edioic Acid Disodium (Gadoxetate Disodium) | 2020-04-23 |
20200123179 | FLUORESCENT COMPOUNDS SPECIFIC FOR PLURIPOTENT STEM CELLS AND REPROGRAMMING-READY CELLS AND METHODS OF USING THE SAME | 2020-04-23 |
20200123180 | METHOD FOR PRODUCING DIALKYLAMINOSILANE | 2020-04-23 |
20200123181 | METHOD FOR PREPARING ARYLALKOXYSILANES BY DEHYDROGENATIVE SILYLATION | 2020-04-23 |
20200123182 | PHOSPHONIUM-ION TETHERED TETRACYCLINE DRUGS FOR TREATMENT OF CANCER | 2020-04-23 |
20200123183 | MN(II)-BASED SENSORS TO DETECT ZINC IN VIVO WITH MRI | 2020-04-23 |
20200123184 | PURIFICATION OF OLIGOSACCHARIDES | 2020-04-23 |
20200123185 | SACCHARIDE POLYCONDENSATE, METHOD FOR PRODUCING THE SAME, AND APPLICATION THEREFOR | 2020-04-23 |
20200123186 | A PROCESS FOR THE PREPARATION OF SGLT2 INHIBITORS AND INTERMEDIATES THEREOF | 2020-04-23 |
20200123187 | NOVEL BUTANE-TETRAOL-BASED AMPHIPHILIC COMPOUNDS AND USES THEREOF | 2020-04-23 |
20200123188 | SYNTHETIC MOLECULE CONSTRUCTS | 2020-04-23 |
20200123189 | SYNTHETIC ROUTE TO 2'-DEOXY-2',2'-DIFLUOROTETRAHYDROURIDINES | 2020-04-23 |
20200123190 | 5'-POSITION DIBENZYL MONOPHOSPHATE DERIVATIVE OF NUCLEOSIDE-BASED ANTICANCER AGENT OR ANTIVIRUS AGENT | 2020-04-23 |
20200123191 | PHARMACEUTICAL AGENTS, COMPOSITIONS, AND METHODS RELATING THERETO | 2020-04-23 |
20200123192 | COMPOUNDS AND METHODS USED IN ASSESSING MONO-PARP ACTIVITY | 2020-04-23 |
20200123193 | CHARGE-TAGGED NUCLEOTIDES AND METHODS OF USE THEREOF | 2020-04-23 |
20200123194 | COMPOSITION COMPRISING NOVEL GINSENOSIDE | 2020-04-23 |
20200123195 | OXYSTEROLS AND METHODS OF USE THEREOF | 2020-04-23 |
20200123196 | A PROCESS FOR PREPARATION OF A PEPTIDE | 2020-04-23 |
20200123197 | METHOD OF MAKING A CROSS METATHESIS PRODUCT | 2020-04-23 |
20200123198 | Peptide Libraries and Methods of Use | 2020-04-23 |
20200123199 | ACETYLCHOLINE RECEPTOR-BINDING PEPTIDE | 2020-04-23 |
20200123200 | TREATMENT OF HAEMATOLOGICAL MALIGNANCIES | 2020-04-23 |
20200123201 | PEPTIDE COMPOSITIONS AND METHODS OF USE | 2020-04-23 |
20200123202 | MODULATION OF COMPLEMENT ACTIVITY | 2020-04-23 |
20200123203 | COMPOSITIONS COMPRISING CURONS AND USES THEREOF | 2020-04-23 |
20200123204 | RECOMBINANT ONCOLYTIC VIRUSES FOR TREATMENT OF METASTATIC CANCERS | 2020-04-23 |
20200123205 | Inhibition Of TCR Signaling With Peptide Variants | 2020-04-23 |
20200123206 | NEISSERIA MENINGITIDIS COMPOSITION AND METHODS THEREOF | 2020-04-23 |
20200123207 | VIRULENCE ATTENUATED BACTERIA BASED PROTEIN DELIVERY | 2020-04-23 |
20200123208 | PEPTIDES AND NEMATICIDAL COMPOSITIONS | 2020-04-23 |
20200123209 | ANTIMICROBIAL TYPE-II BACTERIOCINS | 2020-04-23 |
20200123210 | IMMUNOGENIC PREPARATIONS AND METHODS AGAINST CLOSTRIDIUM DIFFICILE INFECTION | 2020-04-23 |
20200123211 | COMPOSITIONS AND RELATED METHODS FOR MODULATING TRANSCRIPTIONAL ACTIVATION BY INCORPORATING GAG MOTIFS UPSTREAM OF CORE PROMOTER ELEMENTS | 2020-04-23 |
20200123212 | PEPTIDES FOR BINDING EPIDERMAL GROWTH FACTOR | 2020-04-23 |
20200123213 | IMMUNOGENIC PROTEINS AND FRAGMENTS THEREOF FROM ALLERGENIC MITES | 2020-04-23 |
20200123214 | CSF1R-BASED CHIMERIC PROTEINS | 2020-04-23 |
20200123215 | Double-Acylated GLP-1 Derivatives | 2020-04-23 |
20200123216 | COMPOUNDS WITH REDUCED RING SIZE FOR USE IN DIAGNOSING AND TREATING MELANOMA, INCLUDING METASTATIC MELANOMA AND METHODS RELATED TO SAME | 2020-04-23 |
20200123217 | CHIMERIC NK RECEPTOR AND METHODS FOR TREATING CANCER | 2020-04-23 |
20200123218 | OPTOGENETIC PROBES FOR MEASURING MEMBRANE POTENTIAL | 2020-04-23 |
20200123219 | SYSTEMS AND METHODS TO IMPROVE VACCINE EFFICACY | 2020-04-23 |
20200123220 | TCR AND PEPTIDES | 2020-04-23 |
20200123221 | T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME AGAINST PRAME POSITIVE CANCERS | 2020-04-23 |
20200123222 | METHOD FOR IMMOBILIZING LECTIN | 2020-04-23 |
20200123223 | SINGLE-CHAIN GITR-RECEPTOR AGONIST PROTEINS | 2020-04-23 |
20200123224 | METHODS OF EXOGENOUS DRUG ACTIVATION OF CHEMICAL-INDUCED SIGNALING COMPLEXES EXPRESSED IN ENGINEERED CELLS IN VITRO AND IN VIVO | 2020-04-23 |
20200123225 | METHODS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF THE INTERLEUKIN-35 RECEPTOR COMPLEX | 2020-04-23 |
20200123226 | SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR COMPOSITIONS | 2020-04-23 |
20200123227 | INTERFERON PRODRUG FOR THE TREATMENT OF CANCER | 2020-04-23 |
20200123228 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO IMMUNOTHERAPEUTIC ANTIBODIES | 2020-04-23 |
20200123229 | FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY | 2020-04-23 |
20200123230 | Diagnosis of Blistering Autoimmune Disease | 2020-04-23 |
20200123231 | COLLAGEN-BASED BIOMATERIAL | 2020-04-23 |
20200123232 | STABLE POOLED BREASTMILK ANTIBODIES FOR ORAL DELIVERY | 2020-04-23 |
20200123233 | AMINO ACID SEQUENCES DIRECTED AGAINST ENVELOPE PROTEINS OF A VIRUS AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF VIRAL DISEASES | 2020-04-23 |
20200123234 | AGENTS FOR INFLUENZA NEUTRALIZATION | 2020-04-23 |
20200123235 | BIOMIMETIC POLYMERS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES | 2020-04-23 |
20200123236 | MULTISPECIFIC ANTIBODIES TARGETING HUMAN IMMUNODEFICIENCY VIRUS AND METHODS OF USING THE SAME | 2020-04-23 |
20200123237 | ANTIBODIES AND METHODS OF USE THEREOF IN TREATMENT OF INFECTIOUS DISEASE | 2020-04-23 |
20200123238 | EFFICACY OF AN ANTI-C5 ANTIBODY IN THE PREVENTION OF ANTIBODY MEDIATED REJECTION IN SENSITIZED RECIPIENTS OF A KIDNEY TRANSPLANT | 2020-04-23 |
20200123239 | TAU IMMUNOTHERAPY | 2020-04-23 |
20200123240 | HEAVY CHAIN ONLY ANTIBODIES TO PDGF | 2020-04-23 |
20200123241 | COMPOUNDS AND METHODS FOR TREATING PAIN | 2020-04-23 |
20200123242 | USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA | 2020-04-23 |
20200123243 | USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING FIBROSIS | 2020-04-23 |
20200123244 | METHOD FOR PREPARING NEW TYPE OF RECOMBINANT ANTI-TNF- α CHIMERIC MONOCLONAL ANTIBODY AND USE | 2020-04-23 |
20200123245 | METHOD FOR PREVENTING OR REDUCING POST-OPERATIVE COGNITIVE DYSFUNCTION (POCD) | 2020-04-23 |
20200123246 | INHIBITING GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR (GM-CSF) PREVENTS PRETERM BIRTH | 2020-04-23 |
20200123247 | MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4) | 2020-04-23 |
20200123248 | ANTI-IgM/B CELL SURFACE ANTIGEN BISPECIFIC ANTIBODY | 2020-04-23 |
20200123249 | METHODS OF TREATING CANCERS USING ANTI-GPRC5D ANTIBODIES | 2020-04-23 |
20200123250 | NUCLEIC ACID MOLECULES ENCODING ANTI-GPRC5D ANTIBODIES | 2020-04-23 |
20200123251 | Purification Process for Removal of Tyrosine Sulfation Antibody Variants; Purified Compositions | 2020-04-23 |
20200123252 | BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47 | 2020-04-23 |
20200123253 | ANTIBODY FOR TREATING AUTOIMMUNE DISEASES | 2020-04-23 |
20200123254 | Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy | 2020-04-23 |
20200123255 | HUMANIZED OR CHIMERIC CD3 ANTIBODIES | 2020-04-23 |
20200123256 | CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | 2020-04-23 |
20200123257 | ICOS BINDING PROTEINS | 2020-04-23 |